ArticleJournal of thoracic disease2024

The value of high-risk clinicopathologic features for chemotherapy in stage I non-small cell lung cancer: a propensity score-matched study.

Kun Luan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.